Assertio Holdings, Inc. to Host Investor and Business Development Meetings January 9-11, 2023 in San Francisco
Rhea-AI Summary
Assertio Holdings (NASDAQ: ASRT) will conduct one-on-one investor and business development meetings in San Francisco from January 9-11, 2023, coinciding with the annual JP Morgan Healthcare Conference. The meetings aim to discuss investment opportunities and potential partnerships. Interested parties can reach out to Matt Kreps for investor inquiries or Vanessa Fox for business development meetings via the provided contact information. Assertio is focused on expanding its portfolio through acquisitions and licensing of approved products.
Positive
- None.
Negative
- None.
News Market Reaction – ASRT
On the day this news was published, ASRT gained 5.36%, reflecting a notable positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
Meetings to Take Place Adjacent to JP Morgan Healthcare Conference
LAKE FOREST, Ill., Dec. 13, 2022 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (NASDAQ: ASRT), a specialty pharmaceutical company offering differentiated products to patients, today announced that its executive team will host one-on-one investor and business development meetings in San Francisco January 9-11, 2023. The individual meetings will take place at the same time as the annual JP Morgan Healthcare Conference.
For more information and to schedule an investor meeting, please contact Matt Kreps, investor relations for Assertio, at mkreps@darrowir.com. To arrange a business development meeting, please contact Vanessa Fox, Vice President, Business Development and Commercial Analytics for Assertio, at vfox@assertiotx.com.
About Assertio
Assertio is a specialty pharmaceutical company offering differentiated products to patients utilizing a non-personal promotional model. We have built and continue to build our commercial portfolio by identifying new opportunities within our existing products as well as acquisitions or licensing of additional approved products. To learn more visit www.assertiotx.com.
Investor Contact:
Matt Kreps
Managing Director
Darrow Associates
M: 214-597-8200
mkreps@darrowir.com
FAQ
What is Assertio Holdings planning during the JP Morgan Healthcare Conference?
How can I schedule a meeting with Assertio Holdings during the conference?
What is the focus of Assertio Holdings as a company?
When will the Assertio Holdings meetings take place?
What is the stock symbol for Assertio Holdings?
